Chronic hepatitis C and eye diseases: State of the problem


Chernakova G.M., Kleshcheva E.A., Hatsu­kova B.N., Malinnikova E.Yu., Mikhailov M.I.

Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, Moscow, Russia
The relationship of liver diseases to eye problems has been noted since ancient times, and the works of contemporary Russian and foreign researchers only confirm this proposition. Chronic hepatitis C (CHC), apart from liver injury, is characterized by a wide spectrum of extrahepatic manifestations; eye tissues being no exception. In CHC, there are changes in both the anterior and posterior segments of the eye, the clinical features of which are given in this review.
Keywords: cataract, dry eye syndrome, corneoconjunctival xerosis, lacrimal dysfunction syndrome, PCR, hepatitis C virus, chronic hepatitis C
Read entire article

Literature

1. Gupalo O. D. [Ophthalmopathology in patients with chronic diffuse liver diseases]. Cand. Med. Diss. Moscow, 1998. (In Russ).

2. Logay I.M., Petrunya A.M., Frolov V.M. [Eye pathology in diseases of the liver]. Odessa: Ol’vija; 1998. 435 p. (In Russ).

3. Slepova O. S., Kushnir V. N. [The role of immunopathological reactions in the development of eye diseases in persons infected with hepatitis B virus, and the effectiveness of immunocorrective therapy]. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2003; (5):15–21. (In Russ).

4. Mikhaylov M. I., Mamedov M. K. Virusnye gepatity u onkologicheskih bol’nyh [A viral hepatitis at oncologic patients]. Moscow: VK Publ.; 2012. 228 р. (In Russ).

5. Sherman A.C., Sherman K.E. Extrahepatic Manifestations of Hepatitis C Infection: Navigating CHASM. Current HIV/AIDS Reports. 2015, 12(Issue 3): 353–61.

6. Zegans M.E., Anninger W., Chapman C., Gordon S.R. Ocular manifestations of hepatitis C virus infection. Curr. Opin. Ophthalmol. 2002; 13(6): 423–7.

7. Pazienza V. Ophthalmological complications in hepatitis C virus infection: side effect of interferon therapy or a direct role of HCV? Biomed. Pharmacother. 2011; 65(4): 317–8.

8. Maichuk D.Yu. [Pathogenetic substantiation of treatment and prevention of secondary disorders of tear production]. Dr. Med. Diss. Moscow, 2005. (In Russ).

9. Polunina T. E., Batmanov, Y. E., Polunina E. V. [Dry eye Syndrome as a complication of chronic viral hepatitis C]. Medicinskaya pomoshh’ 2009; (3): 30–2. (In Russ).

10. Jorgensen C., Legouffe M.C., Perney P., Coste J., Tissot B., Segarra C., Bologna C., Bourrat L., Combe B., Blanc F., Sany J. Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum. 1996; 39(7): 1166–71.

11. Feucht H.H., Zollner B., Schroter M., Altrogge H., Laufs R. Tear fluid of hepatitis C virus carriers could be infectious. J. Clin. Microbiol. 1995; 33(8): 2202–3.

12. Feucht H.H., Polywka S., Zollner B., Laufs R. Greater amount of HCV-RNA in tears compared to blood. Microbiol Immunol. 1994; 38(2): 157–8.

13. Mendel I., Muraine M., Riachi G., Forzli F., Bertin C., Colin R., Brasseur G., Buffet-Janvresse C. Detection and genotyping of the hepatitis C RNA in tear fluid from patients with chronic hepatitis C. J. Med. Virol. 1997; 51(3): 231–3.

14. Jacobi C., Wenkel H., Jacobi A., Korn K., Cursiefen C., Kruse F.E. Hepatitis C and ocular surface disease. Am. J. Ophthalmol. 2007; 144(5): 705–11.

15. Zeni L.P., Viera P.D., Michalczuk M.T., Birkhan O.A., Vilela M.A., Alvares-da-Silva M.R. Hepatitis C virus induces abnormalities in surface and intraocular pressure: a comparative study. Eur. J. Gastroenterol. Hepatol. 2013; 25(4): 411–5.

16. Akberova G.E., Saifullina F.R. [Features of a slezoobrazovaniye at patients with chronic hepatitis C]. Kazanskiy meditsinskiy zhurnal 2012; 93(6): 956–8. (In Russ).

17. Akberova G.E., Saifullina F.R., Hayertynova I.M. [Features of ophthalmologic disturbances at a chronic viral hepatitis of C before antiviral therapy]. Kazanskiy meditsinskiy zhurnal 2012; 93(6): 989–91. (In Russ).

18. Zegans M.E., Anninger W., Chapman C., Gordon S.R. Ocular manifestations of hepatitis C virus infection. Curr. Opin. Ophthalmol. 2002; 13(6): 423–7.

19. Ramos-Casals M., Loustaud-Ratti V., De Vita S., Zeher M., Bosch J.A., Toussirot E., Medina F., Rosas J., Anaya J.M., Font J. SS-HCV Study Group. Sjogren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 2005; 84(2): 81–9.

20. Vitali C. Immunopathologic differences of Sjogren’s syndrome versus sicca syndrome in HCV and HIV infection. Arthritis Res. Ther. 2011; 13(4): 233–9.

21. Brito-Zeron P., Gheitasi H., Retamozo S.. How hepatitis C virus modifies the immunological profile of Sjogren syndrome: analysis of 783 patients. Arthritis Res. Ther. 2015; 17(1): 250.

22. Alves M., Angerami R.A., Rocha E.M. Dry eye disease caused by viral infection: review, 2013. Arq. Bras. Oftalmol. 2013; 76(2): 129–32.

23. Rajalakshmy A.R., Malathi J., Madhavan H.N., Bhaskar S., Iyer G.K. Patients with dry eye without hepatitis C virus infection possess the viral RNA in their tears. Cornea 2015; 34(1): 28–31.

24. Yang W.J., Yang Y.N., Cao J., Man Z.H., Yuan J., Xiao X., Xing Y. Risk Factors for Dry Eye Syndrome: A Retrospective Case-Control Study. Optom. Vis. Sci. 2015; 92(9): e199–е205.

25. Karaman E.S., Kulac K.D., Kocabora M.S., Ozsutcu M., Gulkilik I.G., Demirci G., Eliacik M. Ocular surface and tear parameters in patients with chronic hepatitis C at initial stages of hepatic fibrosis. Eye Contact Lens 2015; 41(2): 117–20.

26. Baratz K.H., Fulcher S.F., Bourne W.M. Hepatitis C-associated keratitis. Arch. Ophthalmol. 1998; 116(4): 529–30.

27. Moazami G., Auran J.D., Florakis G.J., Wilson S.E., Srinivasan D.B. Interferon treatment of Mooren’s ulcers associated with hepatitis C. Am. J. Ophthalmol. 1995; 119(3): 365–6.

28. Wilson S.E., Lee W.M., Murakami C., Weng J., Moninger G.A. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology 1994; 101(4): 736–45.

29. Zegans M.E., Srinivasan M., McHugh T., Whitcher J.P., Margolis T.P., Lietman T., Jennette J.C., Cunningham E.T. Jr. Mooren ulcer in South India: serology and clinical risk factors. Am. J. Ophthalmol. 1999; 128(2): 205–10.

30. Jain A.K., Sukhija J., Saini J.S., Chawla Y., Dhiman R.K. Hepatitis C virus-associated keratitis. Eye (Lond.) 2004; 18(2): 131–4.

31. Strobbe E., Cellini M., Campos E.C. Aqueous flare and choroidal thickness in patients with chronic hepatitis C virus infection: a pilot study. Ophthalmology 2013; 120(11): 2258–63.

32. Kobayakawa S., Tochikubo T., Watanabe H., Nomura N. Hepatitis C virus in the aqueous humor. [Article in Japanese]. Nippon Ganka Gakkai Zasshi 1993; 97(9): 1061–4.

33. Yoshida K., Nakano H., Yoshitomi F., Oshika T. Prevalence of seropositivity for hepatitis C virus in cataract patients and the general population. J. Catarac.t Refract. Surg. 2002; 28(10):1789–92.

34. Naeem S.S., Siddiqui E.U., Kazi A.N., Khan S.T., Abdullah F.E., Adhi I. Prevalence of Hepatitis B and Hepatitis C among preoperative cataract patients in Karachi. BMC Res. Notes. 2012; (5): 492.

35. Tahir M.A., Cheema A., Tareen S. Frequency of Hepatitis-B and C in patients undergoing cataract surgery in a tertiary care Centre. Pak. J. Med. Sci. 2015; 31(4): 895–8.

36. Atas M.K., Hashas A.S., Demircan S., Sarıguzel F.M., Baskan B., Yuvacı I., Pangal E., Celik I., Zararsiz G. The Investigation of HCV RNA in Tear Fluid and Aqueous Humor in Patients with Anti-HCV Antibody Positive Who Underwent Cataract Surgery. Ocul. Immunol. Inflamm. 2016; 24(3): 297–301.

37. Abe T., Nakajima A., Satoh N., Koizumi T., Sakuragi S., Ono T, Komatsu M., Masamune O. Clinical characteristics of hepatitis C virus-associated retinopathy. Jpn. J. Ophthalmol. 1995; 39(4): 411–9.

38. Madu A.A., Mayers M. Ocular manifestation of systemic infections. Curr. Opin. Ophthalmol. 1996; 7(6): 85–90.


About the Autors

For correspondence: Bella N. Hatsukova, e-mail: bella-0191@mail.ru


Similar Articles

Back to Content

Бионика Медиа